Skip to main content
. 2014 Feb 12;2014:527470. doi: 10.1155/2014/527470

Figure 1.

Figure 1

Effects of 5-year treatment with long-acting TU on (a) waist circumference (cm), (b) body weight (Kg), and (c) glucose homeostasis (HBA1c) in 40 hypogonadal men (T < 11 nmol/L) with metabolic syndrome (IDF). P variations were evaluated yearly in the testosterone treatment (TRT) versus controls (CTRL).